Drug Profile
Monoclonal antibody 42/6
Latest Information Update: 27 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Transferrin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Sep 1998 Profile reviewed
- 05 Jan 1996 Phase-I clinical trials for Cancer in USA (IV-infusion)